Chapter 26. Drugs and Cosmetics
Article 1. General Provisions
- NMS § 26-1-1 Short Title
- NMS § 26-1-2 Definitions
- NMS § 26-1-3 Prohibited Acts
- NMS § 26-1-3.1 Repealed
- NMS § 26-1-3.2 Prescription Drug Donation
- NMS § 26-1-4 Power to Enjoin Violations
- NMS § 26-1-5 Penalty; Exemptions
- NMS § 26-1-6 Detection of Drugs, Devices Or Cosmetic Believed Adulterated, Misbranded Or Counterfeit; Condemnation; Destruction Or Correction of Defect; Forfeiture and Sale
- NMS § 26-1-7 Attorney General Or District Attorney to Institute Prosecutions
- NMS § 26-1-8 Minor Violations of Act; Warnings Authorized
- NMS § 26-1-9 Addition of Poisonous Or Deleterious Substances; Color Additives
- NMS § 26-1-10 Drug Or Device Adulteration
- NMS § 26-1-11 Drug Or Device; Misbranding
- NMS § 26-1-12 False Advertising
- NMS § 26-1-13 Packaging and Labeling Requirements; Proprietary Preparations
- NMS § 26-1-14 New Drugs; Prerequisites to Sale, Delivery Or Giving Away; Exceptions
- NMS § 26-1-15 Dangerous Drugs; Veterinary Use; Limitations
- NMS § 26-1-16 Dangerous Drugs-Conditions For Sale-Prescription Refilling-Limitations
- NMS § 26-1-16.1 Opioids-Requiring Practitioners to Obtain and Review Reports From the Prescription Monitoring Program
- NMS § 26-1-17 Testing Laboratory
- NMS § 26-1-18 Promulgating Regulations; Procedure
- NMS § 26-1-18.1 Prescription Drug Prior Authorization Protocols
- NMS § 26-1-19 Power to Make Inspections and Secure Samples
- NMS § 26-1-20 Personnel
- NMS § 26-1-21 Power of Board to Publish Reports and Disseminate Information
- NMS § 26-1-22 Unlawful Means of Obtaining Dangerous Drugs Enumerated
- NMS § 26-1-23 False Statements; False Pretenses; Forgery of Labels Or Prescriptions Prohibited
- NMS § 26-1-24 Cosmetics; Misbranding
- NMS § 26-1-25 Cosmetics; Adulteration
- NMS § 26-1-26 Penalties
Article 2. Drug Abuse
Article 2a. Controlled Substances Therapeutic Research
- NMS § 26-2A-1 Short Title
- NMS § 26-2A-2 Purpose
- NMS § 26-2A-3 Definitions
- NMS § 26-2A-4 Lynn Pierson Therapeutic Research Program Established; Participation
- NMS § 26-2A-5 Patient Qualification Review Board; Composition; Powers and Duties
- NMS § 26-2A-6 Lynn Pierson Therapeutic Research Program; Distribution
- NMS § 26-2A-7 Report
Article 2b. Lynn and Erin Compassionate Use Act
- NMS § 26-2B-1 Short Title
- NMS § 26-2B-2 Purpose of Act
- NMS § 26-2B-3 Definitions
- NMS § 26-2B-4 Exemption From Criminal and Civil Penalties For the Medical Use of Cannabis
- NMS § 26-2B-5 Prohibitions, Restrictions and Limitations On the Medical Use of Cannabis-Criminal Penalties
- NMS § 26-2B-6 Advisory Board Created-Duties
- NMS § 26-2B-6.1 Program Regulation and Administration-Fees-Limitations-Rulemaking-Licensure-Issuance-Reporting
- NMS § 26-2B-7 Registry Identification Cards-Department Rules-Duties-Reciprocity
- NMS § 26-2B-7.1 Registry Identification Card-Registration-Renewal-Written Certification
- NMS § 26-2B-8 Thc Content-No Limitation
- NMS § 26-2B-9 Employment Protections
- NMS § 26-2B-10 Persons Under State Supervision-Protections